Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway
Ge Wang, Lu Li, Yan Li, Lihong Zhang
Topics & Concepts
CisplatinCancer researchMAPK/ERK pathwayCateninChemistryOvarian cancerMedicineWnt signaling pathwayCancerSignal transductionInternal medicineChemotherapyBiochemistryPhytochemical compounds biological activitiesBeetle Biology and Toxicology StudiesNatural Compounds in Disease Treatment